Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Killander

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|February 1, 1993
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumorsN Mandahl, B Baldetorp, M Fernö, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experienceT A Alvegard, N O Berg, B Baldetorp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer GroupM Fernö, B Baldetorp, A Borg, et al.
International Journal of Cancer|February 15, 1983
Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublinesI Ernberg, G Klein, B C Giovanella, et al.
Cytometry|January 1, 1992
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometryB Baldetorp, M Fernö, A Fallenius, et al.
The British Journal of Dermatology|June 1, 1994
Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiationK Svanberg, T Andersson, D Killander, et al.
British Journal of Cancer|January 1, 1991
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosisA Borg, H Sigurdsson, G M Clark, et al.
Breast Cancer Research and Treatment|January 1, 1995
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferationM Fernö, B Baldetorp, P O Bendahl, et al.
Cancer Research|July 15, 1990
HER-2/neu amplification predicts poor survival in node-positive breast cancerA Borg, A K Tandon, H Sigurdsson, et al.
British Journal of Cancer|May 1, 1995
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosolsA Borg, J Lennerstrand, M Stenmark-Askmalm, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|February 1, 1993
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumorsN Mandahl, B Baldetorp, M Fernö, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experienceT A Alvegard, N O Berg, B Baldetorp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer GroupM Fernö, B Baldetorp, A Borg, et al.
International Journal of Cancer|February 15, 1983
Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublinesI Ernberg, G Klein, B C Giovanella, et al.
Cytometry|January 1, 1992
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometryB Baldetorp, M Fernö, A Fallenius, et al.
The British Journal of Dermatology|June 1, 1994
Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiationK Svanberg, T Andersson, D Killander, et al.
British Journal of Cancer|January 1, 1991
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosisA Borg, H Sigurdsson, G M Clark, et al.
Breast Cancer Research and Treatment|January 1, 1995
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferationM Fernö, B Baldetorp, P O Bendahl, et al.
Cancer Research|July 15, 1990
HER-2/neu amplification predicts poor survival in node-positive breast cancerA Borg, A K Tandon, H Sigurdsson, et al.
British Journal of Cancer|May 1, 1995
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosolsA Borg, J Lennerstrand, M Stenmark-Askmalm, et al.
Pageof 9